TickerFactsScreenerDevelopers

Rein Therapeutics, Inc. (RNTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$12.89M2016: -$18.17M2017: -$23.01M2018: -$31.90M2019: -$29.96M2020: -$20.50M2021: -$26.61M2022: -$27.65M2023: -$16.28M2024: -$65.11M2025: -$50.63M-$50.63M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$50.63M+22.2%
2024-$65.11M-300.0%
2023-$16.28M+41.1%
2022-$27.65M-3.9%
2021-$26.61M-29.8%
2020-$20.50M+31.6%
2019-$29.96M+6.1%
2018-$31.90M-38.7%
2017-$23.01M-26.6%
2016-$18.17M-40.9%
2015-$12.89M—